✦ LIBER ✦
Twenty-four-month α-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters
✍ Scribed by J. W. Koskenvuo; J. J. Hartiala; P. Nuutila; R. Kalliokoski; J. S. Viikari; E. Engblom; M. Penttinen; J. Knuuti; I. Mononen; I. M. Kantola
- Book ID
- 106374364
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 339 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.